Analytes/procedures in bold
type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
- Three 1.5-mL non-infectious liquid specimens that contain the whole SARS-CoV-2 genome
- Designed for molecular techniques
- Provides sequence targets across all assay platforms
- Shipment A: May 18
- Shipment B: December 14